| Feb. 1999 |
Japan Tissue Engineering Co., Ltd established as a joint venture. Operations begun at Hama-cho, Gamagori. |
| Sep. 1999 |
Relocated the head office to Miyakidadori, Gamagori. |
| Nov. 2000 |
Awarded the Chubu Bureau of International Trade and Industry Prize in the New Business Awards Division of the Chubu New Business Awards, sponsored by the Chubu New Business Association. |
Dec. 2000 |
Submitted application for government approval prior to a clinical trial of Autologous Cultured Epidermis. |
Sept. 2001 |
Submitted application for government approval prior to a clinical trial of Autologous Cultured Cartilage. |
| Jan. 2002 |
Awarded a Special Incentive Award in the 15th Chunichi Industrial Technology Awards sponsored by the Chunichi Shimbun newspaper. |
| Mar. 2002 |
Obtained authorization to begin clinical trials of autologous cultured epidermis. |
| Aug. 2003 |
Full-scale entry into cornea cultivation in collaboration with an Italian eye bank
(The Veneto Eye Bank Foundation). |
| Sep. 2003 |
Started multicenter clinical trials of autologous cultured epidermis. |
| Feb. 2004 |
Obtained authorization to begin clinical trials of autologous cultured cartilage. |
| May 2004 |
Started multicenter clinical trials of autologous cultured cartilage. |
| Jun. 2004 |
Awarded President of the Science Council of Japan's Award at the 16th Awards for Excellence in Collaboration Between Industry, Academia, and Government. |
| Oct. 2004 |
Submitted application for manufacturing and sales approval of Autologous Cultured Epidermis. |
| Nov. 2004 |
Completed construction of new premises and moved in. |
| Mar. 2005 |
Launched sales of LabCyte EPI-MODEL, a cultured human tissue for research use. |
| Oct. 2005 |
Awarded the Japan Bioventure Grand Prize, the top honor in the Fourth Japan Bioventure Grand Prize awards. |
| Nov. 2006 |
Awarded the highest prize in the New Business Awards 2006, sponsored by the Chubu Economic Federation. |
| Nov. 2006 |
Launched sales of LabCyte MELANO-MODEL, a cultured human tissue for research use. |
| Mar. 2007 |
Submitted clinical trial completion notification of Autologous Cultured Cartilage. |
May. 2007 |
Submitted application for government approval prior to a clinical trial of Autologous Cultured Corneal Epithelium. |
| Aug. 2007 |
Developed Cell-Culture Kit for research use. |
| Oct. 2007 |
Received government approval to culture and sell Autologous Cultured Epidermis JACE® for serious burns treatment in Japan. |
| Nov. 2007 |
Submitted a request for health insurance listing of Autologous Cultured Epidermis. |
| Dec. 2007 |
Joined the JASDAQ Securities Exchange's Neo market on December 21. |
| May 2008 |
Entered into an Advisory Agreement with Prof. Howard Green of Harverd Medical School. |
| Jan. 2009 |
Autologous Cultured Epidermis JACE®: Listed as an item covered by the National Health
Insurance in Japan. |
| Aug. 2009 |
Submitted application for manufacturing and sales of Autologous Cultured Cartilage. |
| Jul. 2010 |
Launched sales of LabCyte CORNEA-MODEL, a cultured human tissue for research use. |
| Oct. 2010 |
Issued new shares by third party allocation. The largest shareholder in J-TEC changed from NIDEK Co., Ltd. to FUJIFILM Corporation. (press release) |
| Dec. 2010 |
Established Singapore Representative Office. (press release) |
| Mar. 2011 |
Autologous Cultured Epidermis JACE®: Designated as a medical device for rare diseases for the treatment of epidermolysis bullosa. |
